These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12755662)

  • 1. Metabolic syndrome in patients with schizophrenia.
    Heiskanen T; Niskanen L; Lyytikäinen R; Saarinen PI; Hintikka J
    J Clin Psychiatry; 2003 May; 64(5):575-9. PubMed ID: 12755662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    Suvisaari JM; Saarni SI; Perälä J; Suvisaari JV; Härkänen T; Lönnqvist J; Reunanen A
    J Clin Psychiatry; 2007 Jul; 68(7):1045-55. PubMed ID: 17685741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.
    Saari KM; Lindeman SM; Viilo KM; Isohanni MK; Järvelin MR; Laurén LH; Savolainen MJ; Koponen HJ
    J Clin Psychiatry; 2005 May; 66(5):559-63. PubMed ID: 15889940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.
    Saloojee S; Burns JK; Motala AA
    Early Interv Psychiatry; 2018 Dec; 12(6):1137-1143. PubMed ID: 28402033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.
    Sicras-Mainar A; Blanca-Tamayo M; Rejas-Gutiérrez J; Navarro-Artieda R
    Eur Psychiatry; 2008 Mar; 23(2):100-8. PubMed ID: 17904825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study.
    Rejas J; Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M
    Schizophr Res; 2008 Feb; 99(1-3):23-8. PubMed ID: 18063343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
    Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the metabolic syndrome among patients receiving clozapine.
    Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB
    Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a comprehensive routine outcome monitoring program for people with psychotic disorders: The Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS).
    Bartels-Velthuis AA; Visser E; Arends J; Pijnenborg GHM; Wunderink L; Jörg F; Veling W; Liemburg EJ; Castelein S; Knegtering H; Bruggeman R
    Schizophr Res; 2018 Jul; 197():281-287. PubMed ID: 29395613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual impairment in persons with psychotic disorder.
    Viertiö S; Laitinen A; Perälä J; Saarni SI; Koskinen S; Lönnqvist J; Suvisaari J
    Soc Psychiatry Psychiatr Epidemiol; 2007 Nov; 42(11):902-8. PubMed ID: 17846698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.
    Brostedt EM; Msghina M; Persson M; Wettermark B
    BMC Psychiatry; 2017 Dec; 17(1):416. PubMed ID: 29284436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey.
    Suvisaari J; Perälä J; Saarni SI; Härkänen T; Pirkola S; Joukamaa M; Koskinen S; Lönnqvist J; Reunanen A
    Eur Arch Psychiatry Clin Neurosci; 2008 Apr; 258(3):129-36. PubMed ID: 17990051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France.
    Arbus C; Clement JP; Bougerol T; Fremont P; Lancrenon S; Camus V
    Int Psychogeriatr; 2012 Mar; 24(3):496-502. PubMed ID: 21835072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome among patients with schizophrenia in Palestine.
    Sweileh WM; Zyoud SH; Dalal SA; Ibwini S; Sawalha AF; Ali I
    BMC Psychiatry; 2012 Dec; 12():235. PubMed ID: 23270504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.
    Teixeira PJ; Rocha FL
    Braz J Psychiatry; 2007 Dec; 29(4):330-6. PubMed ID: 18200397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
    Nakonezny PA; Byerly MJ; Rush AJ
    Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.